Russell Investments Group, Ltd. Seagen Inc. Transaction History

Russell Investments Group, Ltd.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$191.51 - $216.16 $1.36 Million - $1.53 Million	-7,078 Reduced 28.65%	17,628 $3.74 Million
Q2 2023 Aug 10, 2023	BUY	$187.64 - $206.25 $844,942 - $928,743	4,503 Added 22.29%	24,706 $4.75 Million
Q1 2023 May 09, 2023	SELL	$127.59 - $203.08 $4.34 Million - $6.9 Million	-33,995 Reduced 62.72%	20,203 $4.09 Million
Q4 2022 Feb 08, 2023	BUY	$117.37 - $139.17 $530,042 - $628,491	4,516 Added 9.09%	54,198 $6.96 Million
Q3 2022 Nov 04, 2022	BUY	$135.27 - $180.11 $4.39 Million - $5.85 Million	32,467 Added 188.6%	49,682 $6.79 Million

Q2 2022 Jul 29, 2022	SELL	$108.81 - $179.33 $97,167 - $160,141	-893 Reduced 4.93%	17,215 $3.05 Million
Q1 2022 May 05, 2022	SELL	$119.61 - $157.85 $973,266 - $1.28 Million	-8,137 Reduced 31.0%	18,108 $2.6 Million
Q4 2021 Jan 21, 2022	SELL	$142.57 - $190.86 $126,602 - $169,483	-888 Reduced 3.27%	26,245 $4.06 Million
Q3 2021 Nov 08, 2021	SELL	$142.45 - $169.82 $965,098 - $1.15 Million	-6,775 Reduced 19.98%	27,133 $4.59 Million
Q2 2021 Aug 04, 2021	BUY	$135.08 - $161.1 $266,512 - $317,850	1,973 Added 6.18%	33,908 $5.35 Million
Q1 2021 May 10, 2021	BUY	$137.51 - $190.8 $4.39 Million - $6.09 Million	31,935 New	31,935 $4.43 Million

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

Stay updated on Russell Investments Group, Ltd. with notifications on news.